These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 15109513

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serotonin metabolism in chronic tension-type headache.
    Bendtsen L, Jensen R, Hindberg I, Gammeltoft S, Olesen J.
    Cephalalgia; 1997 Dec; 17(8):843-8. PubMed ID: 9453272
    [Abstract] [Full Text] [Related]

  • 28. N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.
    Bismuth-Evenzal Y, Roz N, Gurwitz D, Rehavi M.
    Biochem Pharmacol; 2010 Nov 15; 80(10):1546-52. PubMed ID: 20696140
    [Abstract] [Full Text] [Related]

  • 29. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache.
    Bendtsen L, Jensen R.
    Neurology; 2004 May 25; 62(10):1706-11. PubMed ID: 15159466
    [Abstract] [Full Text] [Related]

  • 30. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
    Tseng YL, Braun A, Chang JP, Chiang ML, Tseng CY, Chen W.
    Toxicol Appl Pharmacol; 2019 Feb 01; 364():106-113. PubMed ID: 30592962
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers.
    Penttilä J, Syvälahti E, Hinkka S, Kuusela T, Scheinin H.
    Psychopharmacology (Berl); 2001 Apr 01; 154(4):343-9. PubMed ID: 11349386
    [Abstract] [Full Text] [Related]

  • 34. Impact of escitalopram on nocturnal sleep, day-time sleepiness and performance compared to amitriptyline: a randomized, double-blind, placebo-controlled study in healthy male subjects.
    Doerr JP, Spiegelhalder K, Petzold F, Feige B, Hirscher V, Kaufmann R, Riemann D, Voderholzer U.
    Pharmacopsychiatry; 2010 Jul 01; 43(5):166-73. PubMed ID: 20603788
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    Blier P, Saint-André E, Hébert C, de Montigny C, Lavoie N, Debonnel G.
    Int J Neuropsychopharmacol; 2007 Feb 01; 10(1):41-50. PubMed ID: 16690005
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
    Auerbach SB, Hjorth S.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec 01; 352(6):597-606. PubMed ID: 9053730
    [Abstract] [Full Text] [Related]

  • 40. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.
    Encephale; 2007 Dec 01; 33(6):965-72. PubMed ID: 18789789
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.